Integrating treatments for opioid use disorders into medical care: the role of buprenorphine and naltrexone

Dr. Todd Korthuis, M.D., M.P.H.
Associate Professor of Medicine, Oregon Health & Science University

Click here to RSVP.
Event is free, lunch provided.


Event Details

Days
Hours
Minutes
Seconds
Start Date
  • May 9, 2014 12:00
End Date
  • May 9, 2014 12:00
Email
education@bccfe.ca
Event Category
  • Lecture
Calendar of Events
Click here for the Calendar of Events
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search